Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Masimo by Year
Masimo — U.S. Hospital GPO Pulse Oximetry Revenue ($M)
Danaher Masimo: $873M in FY2025, up 9.9% from a year earlier.
Where the FY2025 figure comes from
“In 2025 and 2024, revenues from the sale of our pulse oximetry products to hospitals that are associated with GPOs amounted to $872.8 million and $794.0 million, respectively.”
Source: Masimo SEC 10-K (FY2025, filed 2026-02-27) ↗
Extracted from standalone SEC Form 10-Q / 10-K filings of subsidiary Masimo Corporation (CIK 0000937556) prior to the completion of its 100% merger into Danaher's Diagnostics segment on 10/06/2026 for $9.8 billion (the final standalone reporting period was FY2026Q1 ended 04/04/2026).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Masimo — U.S. Hospital GPO Pulse Oximetry Revenue ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 873 | +9.9% | Masimo SEC 10-K (FY2025, filed 2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 794 | – | Masimo SEC 10-K (FY2025, filed 2026-02-27) ↗ |
Cite this data
StockData. (2026). Danaher Masimo ($M), annual FY2024–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/masi-gpo-hospital-rev
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.